Displaying 3461 - 3480 of 4804
FTC Issues Agenda for Workshop to Explore the Role of Patented Technology in Collaborative Industry Standards
FTC Seeks Public Comment on Universal Health Services' Application to Sell Las Vegas Psychiatric Facilities
FTC Challenges Grifols/Talecris Merger as Anticompetitive
FTC Staff Comment Before the Federal Energy Regulatory Commission Concerning Analysis of Horizontal Market Power under the Federal Power Act (Docket No. RM11-14-000)
FTC Conditions Irving Oil's Proposed Acquisition of ExxonMobil Assets in Maine
FTC Files Amicus Brief in U.S. Court of Appeals for the Third Circuit in K-Dur Antitrust Litigation Urging Reversal of Pay-for-Delay Ruling
International Competition Network Presents Vision for its Second Decade
FTC Chairman Leibowitz, Commissioner Kovacic to Participate in 10th Annual International Competition Network Conference In The Hague, The Netherlands
FTC Staff Says Proposed Massachusetts Law Would Limit Competition and Raise Costs in Distribution of Malt Beverages
FTC Settlement Order Bars Texas Doctors' Group from Joint Price Negotiations
FTC Staff Finds Sanofi-Aventis, Watson Pharmaceuticals, and Synthon Holding B.V. Failed to Report Drug Patent Agreements as Required by Law
Another Dose of Competition: Accountable Care Organizations and Antitrust
FTC to Host Public Forum on Competition Issues in Standard-Setting
FTC Seeking Public Comments on Application by Tops Markets to Sell Three Former Penn Traffic Supermarkets in Cortland and Ithaca, New York, and Sayre, Pennsylvania
FTC Approves Dow Chemical Application to Amend Agreement with Huntsman Related to Union Carbide Acquisition
Dow Chemical Company, The, and Union Carbide Corporation
Dow settled antitrust concerns relating to its proposed merger with Union Carbide Corporation. Dow agreed to divest and license intellectual property necessary to the production of linear low-density polyethylene -an ingredient used in premium plastic products such as trash bags and sealable food pouches -to BP Amoco plc.
FTC Staff Report Finds 60 Percent Increase in Pharmaceutical Industry Deals That Delay Consumers' Access to Lower-Cost Generic Drugs
FTC Announces Public Workshop on Antitrust and Accountable Care Organizations
FTC Requires Hikma to Sell Two Drugs as Condition of Baxter Healthcare Acquisition
Displaying 3461 - 3480 of 4804